aml risk stratification
Published 2 years ago • 382 plays • Length 2:03Download video MP4
Download video MP3
Similar videos
-
3:47
the impact of cytogenetic-risk stratification on aml outcomes
-
2:31
updates in the diagnosis, risk stratification & treatment of aml: who, icc, and eln classifications
-
1:28
the role of allogeneic transplantation in patients with aml in the frontline setting
-
0:55
the role of rna modifications in mds and aml
-
2:12
allosct for aml with mds-related features as per the icc and who 2022 classifications
-
2:57
the importance of analyzing cytogenetic risk in patients with aml undergoing haploidentical sct
-
4:16
glofitamab plus r-chop in patients with high-risk lbcl: a phase ii trial
-
7:46
updates in aml treatment and research from asco 2023
-
7:53
5 tips for caregivers of individuals with acute myeloid leukemia (aml)
-
2:49
results from the phase iii echo trial of acalabrutinib plus br in mcl
-
2:34
the evolution of the aml treatment paradigm
-
1:21
trends in allosct for good-risk aml: a longitudinal study
-
2:45
continuity of care for patients with hematological predispositions to aml
-
1:21
the prognostic impact of secondary-type mutations in patients with favorable risk aml
-
1:11
the treatment of aml within the united kingdom nhs framework
-
2:43
gemtuzumab ozogamicin in frontline aml therapy
-
8:21
quazar aml-001: a new standard for aml maintenance therapy
-
1:19
astx727 a molecularly-targeted agent as personalized maintenance therapy in patients with aml
-
2:09
advances in the management of fit adults with aml
-
1:02
the impact of sequencing in aml
-
1:16
an insight into the beat aml trial and the value of precision medicine